Evolving Technologies for the Packaging and Delivery of Injectable Drugs
Dr. Mike Schäfers
West Pharmaceutical Services, Eschweiler, Germany
The global pharmaceutical industry has faced significant changes in market conditions. The slow-down of innovations in R&D, patent expirations, the occurrence of pharmerging markets, the increasing importance of biotech products, biosimilars and generics as well as healthcare reforms and cost pressures are just a few examples. As a result, the industry has initiated programs that focus on areas such as globalization, total cost of ownership, partnership with third parties for areas such as research and development, and contract manufacturing. At the same time, pharmaceutical companies have placed more emphasis on container closure and device selection to minimize drug compatibility issues and address patient needs. In this respect, lifecycle management for product portfolios has gained importance, while product differentiation has become a key tool to achieve higher revenue growth and increased margins against tough competition. Container closure and device selection, as well as lifecycle management, play a key role during product development. In addition, once a product becomes commercial, efficient production, compliance with applicable regulatory and legal standards, and lifecycle management become key focus areas.
pharmind 2011, Nr. 8, Seite 1518